• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成本效益分析的经济基础。

Economic foundations of cost-effectiveness analysis.

作者信息

Garber A M, Phelps C E

机构信息

Veterans Affairs Palo Alto Health Care System, CA, USA.

出版信息

J Health Econ. 1997 Feb;16(1):1-31. doi: 10.1016/s0167-6296(96)00506-1.

DOI:10.1016/s0167-6296(96)00506-1
PMID:10167341
Abstract

To address controversies in the applications of cost-effectiveness analysis, we investigate the principles underlying the technique and discuss the implications for the evaluation of medical interventions. Using a standard von Neumann-Morgenstern utility framework, we show how a cost-effectiveness criterion can be derived to guide resource allocation decisions, and how it varies with age, gender, income level, and risk aversion. Although cost-effectiveness analysis can be a useful and powerful tool for resource allocation decisions, a uniform cost-effectiveness criterion that is applied to a heterogeneous population level is unlikely to yield Pareto-optimal resource allocations.

摘要

为了解决成本效益分析应用中的争议,我们研究了该技术背后的原理,并讨论了其对医疗干预评估的影响。使用标准的冯·诺依曼-摩根斯坦效用框架,我们展示了如何推导成本效益标准以指导资源分配决策,以及它如何随年龄、性别、收入水平和风险厌恶程度而变化。尽管成本效益分析对于资源分配决策可能是一个有用且强大的工具,但应用于异质人群层面的统一成本效益标准不太可能产生帕累托最优的资源分配。

相似文献

1
Economic foundations of cost-effectiveness analysis.成本效益分析的经济基础。
J Health Econ. 1997 Feb;16(1):1-31. doi: 10.1016/s0167-6296(96)00506-1.
2
Accounting for future costs in medical cost-effectiveness analysis.医疗成本效益分析中对未来成本的考量。
J Health Econ. 1997 Feb;16(1):33-64. doi: 10.1016/s0167-6296(96)00507-3.
3
Economic analysis in dermatology.皮肤病学中的经济分析。
J Am Acad Dermatol. 2002 Feb;46(2):271-83. doi: 10.1067/mjd.2002.119566.
4
The importance of patient preferences for comorbidities in cost-effectiveness analyses.患者对合并症的偏好在成本效益分析中的重要性。
J Health Econ. 1997 Feb;16(1):113-9. doi: 10.1016/s0167-6296(96)00510-3.
5
Assigning values to intermediate health states for cost-utility analysis: theory and practice.为成本效用分析为中间健康状态赋值:理论与实践
Med Decis Making. 1996 Oct-Dec;16(4):376-85. doi: 10.1177/0272989X9601600408.
6
Cost-effectiveness analysis and policy choices: investing in health systems.成本效益分析与政策选择:对卫生系统的投资
Bull World Health Organ. 1994;72(4):663-74.
7
Theory and methods of economic evaluation of health care.医疗保健经济评估的理论与方法。
Dev Health Econ Public Policy. 1996;4:1-245.
8
Preference-based measures in economic evaluation in health care.医疗保健经济评估中基于偏好的测量方法。
Annu Rev Public Health. 2000;21:587-611. doi: 10.1146/annurev.publhealth.21.1.587.
9
Global cost-effectiveness of cataract surgery.白内障手术的全球成本效益
Ophthalmology. 2007 Sep;114(9):1670-8. doi: 10.1016/j.ophtha.2006.12.013. Epub 2007 Mar 26.
10
Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.成本效益分析与增量成本效益比:用途与陷阱
Eur J Gastroenterol Hepatol. 2004 Jun;16(6):519-26. doi: 10.1097/00042737-200406000-00003.

引用本文的文献

1
How policymakers value end-of-life treatments for rare and common diseases in China: evidence from a contingent valuation study.中国政策制定者如何看待罕见病和常见疾病的临终治疗:一项条件价值评估研究的证据
Glob Health Res Policy. 2025 Aug 26;10(1):38. doi: 10.1186/s41256-025-00434-w.
2
Efficiency in health care: connecting economic evaluations with implementation objectives.医疗保健中的效率:将经济评估与实施目标联系起来。
Implement Sci Commun. 2025 Jul 26;6(1):77. doi: 10.1186/s43058-025-00763-4.
3
The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review.
国民保健服务体系(NHS)等待名单较长情况下择期外科手术的成本效益:一项针对性综述。
Appl Health Econ Health Policy. 2025 May 9. doi: 10.1007/s40258-025-00975-8.
4
Health Risk and the Value of Life.健康风险与生命价值。
J Public Econ. 2025 May;245. doi: 10.1016/j.jpubeco.2025.105346. Epub 2025 Apr 3.
5
Measuring health-related quality of life in a Chinese Mainland adolescent population: psychometric properties of the Mandarin Chinese self-reported KIDSCREEN-27 and KIDSCREEN-10 index.测量中国大陆青少年人群的健康相关生活质量:中文版 KIDSCREEN-27 和 KIDSCREEN-10 指数的心理测量特性。
BMC Psychol. 2024 Oct 29;12(1):600. doi: 10.1186/s40359-024-01876-6.
6
Clinical Outcomes, Costs, and Value of Surgery Among Older Patients with Colon Cancer at US News and World Report Ranked Versus Unranked Hospitals.美国新闻与世界报道排名医院与未排名医院老年结肠癌患者的手术临床结局、成本和价值。
Ann Surg Oncol. 2024 Dec;31(13):8517-8529. doi: 10.1245/s10434-024-16217-5. Epub 2024 Sep 14.
7
Interventions to reduce leprosy related stigma: A systematic review.减少麻风病相关耻辱感的干预措施:一项系统评价。
PLOS Glob Public Health. 2024 Aug 22;4(8):e0003440. doi: 10.1371/journal.pgph.0003440. eCollection 2024.
8
The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries.不同视角对欧洲不同国家心力衰竭患者远程患者监测成本效益的影响。
Eur J Health Econ. 2025 Feb;26(1):71-85. doi: 10.1007/s10198-024-01690-2. Epub 2024 May 3.
9
Factors influencing medical expenditures in patients with unresolved facial palsy and pharmacoeconomic analysis of upper eyelid lid loading with gold and platinum weights compared to tarsorrhaphy.影响未解决面神经麻痹患者医疗费用的因素以及与睑裂缝合术相比,使用金和铂重量的上睑负重的药物经济学分析。
Health Econ Rev. 2024 Apr 27;14(1):30. doi: 10.1186/s13561-024-00506-6.
10
A principled approach to non-discrimination in cost-effectiveness.基于原则的成本效益非歧视方法。
Eur J Health Econ. 2024 Nov;25(8):1393-1416. doi: 10.1007/s10198-023-01659-7. Epub 2024 Feb 27.